Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Geriatr Oncol. 2012 Feb 10;3(2):82–89. doi: 10.1016/j.jgo.2012.01.005

Table 2.

Prevalence of Comorbidities

<65(n=79) ≥65(n=74) p-value
n (%) n (%)
Arthritis, rheumatism, or other connective tissue disorders 39 (49.4) 44 (59.5) 0.252
Glaucoma 3 (3.8) 7 (9.5) 0.200
Asthma 3 (3.8) 2 (2.7) 1.000
Emphysema or chronic bronchitis 6 (7.6) 1 (1.4) 0.117
High blood pressure 14 (17.7) 35 (47.3) <.001
Heart Trouble 10 (12.7) 18 (24.3) 0.092
Circulation trouble in arms or legs 12 (15.2) 18 (24.3) 0.221
Diabetes 7 (8.9) 5 (6.8) 0.765
Epilepsy 0 (0.0) 0 (0.0) -
Ulcers (of the digestive system) 6 (7.6) 2 (2.7) 0.276
Other stomach or intestinal disorders or gall bladder problems 14 (17.7) 12 (16.2) 0.830
Osteoporosis 13 (16.5) 16 (21.6) 0.537
Liver disease 0 (0.0) 2 (2.7) 0.245
Kidney disease 0 (0.0) 4 (5.4) 0.053
Other urinary tract disorders 8 (10.1) 6 (8.1) 0.781
Stroke 2 (2.5) 3 (4.1) 0.675
Parkinson’s disease 1 (1.3) 2 (2.7) 0.613
Thyroid or other glandular disorders 9 (11.4) 12 (16.2) 0.484
Skin disorders, such as pressure sores, leg ulcers, or severe burns 2 (2.5) 3 (4.1) 0.675
Anemia 4 (5.1) 3 (4.1) 1.000
Broken bones, fractures 10 (12.7) 12 (16.2) 0.648
Other Cancer or leukemia 5 (6.3) 5 (6.8) 1.000

P-values are from fisher’s exact test.